These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36410103)

  • 1. Yishen-Qingli-Huoxue formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR/snai1 signaling.
    Chen C; Sun S; Zhao J; Wu Q; He W; Sun W
    Phytomedicine; 2023 Jan; 108():154546. PubMed ID: 36410103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
    Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
    J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
    Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
    Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.
    Liu B; Jie X; Deng J; Zhang S; Lu F; Liu X; Zhang D
    Phytomedicine; 2023 Jun; 114():154767. PubMed ID: 37001297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway.
    Cai H; Wang J; Luo Y; Wang F; He G; Zhou G; Peng X
    Biomed Pharmacother; 2021 Feb; 134():111098. PubMed ID: 33341058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jian-Pi-Yi-Shen formula ameliorates renal fibrosis-induced anemia in rats with chronic kidney disease.
    Huang H; Huang S; Li C; Zhang C; Wang R; Wei L; Wu J; Mo P; Li Z; Li S; Chen J
    J Ethnopharmacol; 2024 Dec; 335():118607. PubMed ID: 39069029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway.
    Mo Y; Hu D; Yu W; Ji C; Li Y; Liu X; Lu Z
    J Ethnopharmacol; 2023 May; 308():116244. PubMed ID: 36764562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jian-Pi-Yi-Shen Formula Improves Adenine-Induced Chronic Kidney Disease
    Liu X; Deng R; Chen Y; Huang S; Lu J; Zheng L; Xiong G; Li S
    Front Pharmacol; 2022; 13():922707. PubMed ID: 35865941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation.
    Sun X; Huang Y; Zhu S; Yan J; Gan K; Xu Z; Wang S; Kang X; Zhang J; Sun W
    Drug Des Devel Ther; 2022; 16():769-787. PubMed ID: 35355655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jian-Pi-Yi-Shen formula restores iron metabolism from dysregulation in anemic rats with adenine-induced nephropathy.
    Li C; Huang H; Wang R; Zhang C; Huang S; Wu J; Mo P; Yu H; Li S; Chen J
    J Ethnopharmacol; 2023 Aug; 312():116526. PubMed ID: 37088234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of active components in
    Yang F; Li T; Zhang XQ; Gong Y; Su H; Fan J; Wang L; Hu QD; Tan RZ
    Ren Fail; 2024 Dec; 46(2):2375033. PubMed ID: 38967135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
    Cai P; Liu X; Xu Y; Qi F; Si G
    Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betulinic acid attenuates renal fibrosis in rat chronic kidney disease model.
    Sharma A; Thakur R; Lingaraju MC; Kumar D; Mathesh K; Telang AG; Singh TU; Kumar D
    Biomed Pharmacother; 2017 May; 89():796-804. PubMed ID: 28273641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).
    Zhao YY; Cheng XL; Wei F; Bai X; Tan XJ; Lin RC; Mei Q
    J Proteome Res; 2013 Feb; 12(2):692-703. PubMed ID: 23227912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erhuang Formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses.
    Zhang CY; Zhu JY; Ye Y; Zhang M; Zhang LJ; Wang SJ; Song YN; Zhang H
    Biomed Pharmacother; 2017 Nov; 95():520-528. PubMed ID: 28866419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on the intervention of Yishen Huoxue prescription to renal fibrosis through the signal regulation by microRNA-126 to VEGF-Notch].
    Zhong J; Zhao N; Liu C; Hu J; Zhang W; Xiong C; Chen H; Gong C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):991-995. PubMed ID: 30439324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
    Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yishen Jiangzhuo Granules affect tubulointerstitial fibrosis via a mitochondrion-mediated apoptotic pathway.
    Xu YF; Ruan SW; Lin JM; Zhang Z
    Chin J Integr Med; 2015 Dec; 21(12):928-37. PubMed ID: 25956968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
    Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
    Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.